Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL429731 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
NPFF1 receptor/Neuropeptide FF receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5951] [GtoPdb: 300] [UniProtKB: Q9GZQ6] | ||||||||
ChEMBL | Binding affinity to human NPFFR1 expressed in green monkey COS-7 cell membranes by [125I]-1DMeNPFF radioligand based saturation binding assay | B | 8.95 | pKd | 1.13 | nM | Kd | J Med Chem (2020) 63: 12387-12402 [PMID:32673481] |
GtoPdb | - | - | 9.9 | pKi | - | - | - |
Eur J Pharmacol (2002) 451: 245-56 [PMID:12242085]; Neuropharmacology (2007) 52: 376-86 [PMID:17011599]; Neuroscience (2002) 115: 349-61 [PMID:12421602] |
ChEMBL | Displacement of [125I]-1DMeNPFF from recombinant human NPFF1 receptor expressed in CHO cells by TopCount scintillation counting method | B | 10.22 | pKi | 0.06 | nM | Ki | J Med Chem (2021) 64: 7555-7564 [PMID:34008968] |
ChEMBL | Agonist activity at NPFF1R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay | F | 6.56 | pEC50 | 275.42 | nM | EC50 | J Med Chem (2021) 64: 13394-13409 [PMID:34465090] |
ChEMBL | Agonist activity at NPFF1R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay | F | 6.56 | pEC50 | 274 | nM | EC50 | J Med Chem (2021) 64: 13394-13409 [PMID:34465090] |
ChEMBL | Agonist activity at NPFF1 receptor (unknown origin) expressed in HEK293A cells assessed as inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins | F | 6.8 | pEC50 | 158.49 | nM | EC50 | Bioorg Med Chem (2019) 27: 630-643 [PMID:30626554] |
NPFF2 receptor/Neuropeptide FF receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5952] [GtoPdb: 301] [UniProtKB: Q9Y5X5] | ||||||||
ChEMBL | Binding affinity to human NPFFR2 expressed in green monkey COS-7 cell membranes by [125I]-1DMeNPFF radioligand based saturation binding assay | B | 9.43 | pKd | 0.37 | nM | Kd | J Med Chem (2020) 63: 12387-12402 [PMID:32673481] |
ChEMBL | Binding affinity to human NPFFR2 | B | 9.68 | pKd | 0.21 | nM | Kd | J Med Chem (2020) 63: 12387-12402 [PMID:32673481] |
ChEMBL | Displacement of [3H]EYE from human NPFF2 receptor expressed in CHO cell membranes after 1 hr by liquid scintillation spectrophotometric counting | B | 8.92 | pKi | 1.2 | nM | Ki | J Med Chem (2016) 59: 1925-1945 [PMID:26824643] |
GtoPdb | - | - | 9.7 | pKi | - | - | - |
Neuroscience (2002) 115: 349-61 [PMID:12421602]; Br J Pharmacol (2001) 133: 1-4 [PMID:11325787] |
ChEMBL | Displacement of [125I]-1DMeNPFF from recombinant human NPFF2 receptor expressed in CHO cells by TopCount scintillation counting method | B | 10.7 | pKi | 0.02 | nM | Ki | J Med Chem (2021) 64: 7555-7564 [PMID:34008968] |
ChEMBL | Agonist activity at human NPFF2 receptor E5.27A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting | F | 6.21 | pEC50 | 612 | nM | EC50 | J Med Chem (2012) 55: 6124-6136 [PMID:22708927] |
ChEMBL | Agonist activity at human NPFF2 receptor D6.59A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting | F | 6.47 | pEC50 | 341 | nM | EC50 | J Med Chem (2012) 55: 6124-6136 [PMID:22708927] |
ChEMBL | Agonist activity at human NPFF2 receptor Y5.38A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting | F | 6.9 | pEC50 | 126 | nM | EC50 | J Med Chem (2012) 55: 6124-6136 [PMID:22708927] |
ChEMBL | Agonist activity at human NPFF2 receptor F/Y7.35A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting | F | 6.92 | pEC50 | 119 | nM | EC50 | J Med Chem (2012) 55: 6124-6136 [PMID:22708927] |
ChEMBL | Agonist activity at NPFF2R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay | F | 7.37 | pEC50 | 42.66 | nM | EC50 | J Med Chem (2021) 64: 13394-13409 [PMID:34465090] |
ChEMBL | Agonist activity at NPFF2R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay | F | 7.37 | pEC50 | 42.4 | nM | EC50 | J Med Chem (2021) 64: 13394-13409 [PMID:34465090] |
ChEMBL | Agonist activity at NPFF2 receptor (unknown origin) expressed in HEK293A cells assessed as inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins | F | 7.4 | pEC50 | 39.81 | nM | EC50 | Bioorg Med Chem (2019) 27: 630-643 [PMID:30626554] |
ChEMBL | Agonist activity at human NPFF2 receptor Y7.33A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting | F | 7.48 | pEC50 | 33 | nM | EC50 | J Med Chem (2012) 55: 6124-6136 [PMID:22708927] |
ChEMBL | Agonist activity at human NPFF2 receptor F5.34A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting | F | 8.25 | pEC50 | 5.6 | nM | EC50 | J Med Chem (2012) 55: 6124-6136 [PMID:22708927] |
ChEMBL | Agonist activity at human NPFFR2 expressed in CHO cells assessed as inhibition of forskolin-induced intracellular cyclic cAMP accumulation | F | 8.5 | pEC50 | 3.16 | nM | EC50 | J Med Chem (2020) 63: 12387-12402 [PMID:32673481] |
ChEMBL | Agonist activity at human NPFF2 receptor H/Q6.69A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting | F | 8.57 | pEC50 | 2.7 | nM | EC50 | J Med Chem (2012) 55: 6124-6136 [PMID:22708927] |
NPFF2 receptor/Neuropeptide FF receptor 2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523416] [GtoPdb: 301] [UniProtKB: Q924H0] | ||||||||
ChEMBL | Displacement of [125I]-1DMeNPFF from mouse NPFF2R receptor by TopCount scintillation counting method | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (2021) 64: 7555-7564 [PMID:34008968] |
NPFF2 receptor/Neuropeptide FF receptor 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3425] [GtoPdb: 301] [UniProtKB: Q9EQD2] | ||||||||
ChEMBL | Binding affinity for NPPF receptor in rat spinal cord membranes using the radioligand [125I]-[Tyr1]NPFF | B | 9.68 | pKi | 0.21 | nM | Ki | J Med Chem (1994) 37: 3477-3481 [PMID:7932576] |
MAS1 in Mouse [GtoPdb: 150] [UniProtKB: P30554] | ||||||||
GtoPdb | - | - | 6.4 | pEC50 | 400 | nM | EC50 | Cell (2001) 106: 619-32 [PMID:11551509] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]